Indication
Staphylococcus lung abscess
A Staphylococcus lung abscess is a localized, suppurative pulmonary infection marked by microbial necrosis and cavitation of the lung parenchyma, caused specifically by staphylococcal bacteria, most commonly *Staphylococcus aureus*. Read more about Staphylococcus lung abscess
13 drugs 13 manufacturers
Drugs that treat it
Common Staphylococcus lung abscess therapies.
CEFOXITIN (cefoxitin sodium)
CEFOXITIN (cefoxitin sodium)
CEFOXITIN (cefoxitin sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA Staphylococcus lung abscess is a localized, suppurative pulmonary infection marked by microbial necrosis and cavitation of the lung parenchyma, caused specifically by staphylococcal bacteria, most commonly *Staphylococcus aureus*.
Primarily affecting the lower respiratory tract, this condition frequently develops in hospitalized, post-viral, or immunocompromised individuals, as well as persons with a history of intravenous drug use or aspiration.
Pathophysiologically, the disease process is driven by bacterial virulence factors—including cytolytic toxins and necrotizing enzymes—that induce severe tissue destruction, purulent liquefaction, and abscess formation via direct parenchymal invasion or hematogenous seeding from distant bacteremia or septic emboli.
Clinically, it manifests as persistent fever, productive cough with purulent sputum, chest pain, and air-fluid cavitary lesions visible on thoracic imaging.
- nih.gov
A Staphylococcus lung abscess is a localized, suppurative pulmonary infection marked by microbial necrosis and cavitation of the lung parenchyma, caused specifically by staphylococcal bacteria, most commonly *Staphylococcus aureus*
- nih.gov
A Staphylococcus lung abscess is a localized, suppurative pulmonary infection marked by microbial necrosis and cavitation of the lung parenchyma, caused specifically by staphylococcal bacteria, most commonly *Staphylococcus aureus* Pathophysiologically, the disease process is driven by bacterial virulence factors—including cytolytic toxins and necrotizing enzymes—that induce severe tissue destruction, purulent liquefaction, and abscess formation via direct parenchymal invasion or hematogenous se...
- nih.gov
Primarily affecting the lower respiratory tract, this condition frequently develops in hospitalized, post-viral, or immunocompromised individuals, as well as persons with a history of intravenous drug use or aspiration Pathophysiologically, the disease process is driven by bacterial virulence factors—including cytolytic toxins and necrotizing enzymes—that induce severe tissue destruction, purulent liquefaction, and abscess formation via direct parenchymal invasion or hematogenous seeding from di...
- medlineplus.gov
Primarily affecting the lower respiratory tract, this condition frequently develops in hospitalized, post-viral, or immunocompromised individuals, as well as persons with a history of intravenous drug use or aspiration
- merckmanuals.com
Primarily affecting the lower respiratory tract, this condition frequently develops in hospitalized, post-viral, or immunocompromised individuals, as well as persons with a history of intravenous drug use or aspiration Clinically, it manifests as persistent fever, productive cough with purulent sputum, chest pain, and air-fluid cavitary lesions visible on thoracic imaging
- youtube.com
Pathophysiologically, the disease process is driven by bacterial virulence factors—including cytolytic toxins and necrotizing enzymes—that induce severe tissue destruction, purulent liquefaction, and abscess formation via direct parenchymal invasion or hematogenous seeding from distant bacteremia or septic emboli
Personalize your experience
Follow Staphylococcus lung abscess and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.